Press Releases

Hero overlay Cancer research Analyst Coverage Annual Report Proxy Materials Corporate Governance Events Presentations Financial Information Investor Disclaimer Press Releases Stock Information
Broad Commercialization and Scale-Up of Revio Enables Researchers with 15 Times More HiFi Data and High-Quality Human Genomes for Under $1,000 MENLO PARK, Calif. , March 7, 2023 /PRNewswire/ --  PacBio  (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today
March 7, 2023
MENLO PARK, Calif. , Feb. 27, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in Cowen's 43rd Annual Health Care Conference in Boston, Massachusetts .
February 27, 2023
MENLO PARK, Calif. , Feb. 16, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2022 .     Fourth quarter results Received record orders in the fourth quarter, including orders for 96 instruments, which included orders
February 16, 2023

Investor Contact

Pacific Biosciences of California, Inc.
1305 O’Brien Drive, Menlo Park, CA 94025
ir@pacb.com